UK markets closed

Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
74.20+1.20 (+1.64%)
At close: 01:30PM CST

Johnson Chemical Pharmaceutical Works Co., Ltd.

No. 77 and No.79, Sanhe Road
Section 4 Sanchong District
New Taipei City 241
Taiwan
886 2 2989 4756
https://www.jcpjohnson.com.tw

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees167

Key executives

NameTitlePayExercisedYear born
Mr. P. H. HuangChairman & CEON/AN/AN/A
Ms. Grace ChenFinance DirectorN/AN/AN/A
Mr. Weike LinSales DirectorN/AN/AN/A
Guo An LiaoDeputy General Manager and DirectorN/AN/AN/A
Mr. Peter LinChief Research OfficerN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was incorporated in 1959 and is based in New Taipei City, Taiwan.

Corporate governance

Johnson Chemical Pharmaceutical Works Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.